九安醫療(002432.SZ)前三季度預盈3.2億至3.8億元 同比扭虧為盈
格隆匯10月14日丨九安醫療(002432.SZ)公佈,預計2020年前三季度歸屬於上市公司股東的淨利潤3.2億元至3.8億元,上年同期虧損7961.06萬元;其中,第三季度歸屬於上市公司股東的淨利潤6238.23萬元至12238.23萬元,上年同期虧損2988.78萬元。
疫情期間,公司快速響應國內公共衞生防疫需求,提前恢復生產,積極擴大產能,並於2020年3月中旬開始向國外出口額温計等防疫產品,產品銷量的提升對公司本期業績有積極影響。目前海外疫情防控趨勢未顯著緩解,人們防疫觀唸的增強均對防疫產品銷售產生積極影響,消費者對於額温計、血氧儀等產品的需求仍然存在。此外,公司嚴格控制費用產生正面成效,費用佔總收入比例較上期有所下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.